Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Integrated Diagnostics Holdings PLC

Healthcare GB IDHC

0.5899GBX
-0.0001(0.02%)

Last update at 2026-03-10T14:37:00Z

Day Range

0.570.60
LowHigh

52 Week Range

0.300.68
LowHigh

Fundamentals

  • Previous Close 0.59
  • Market Cap217.50M
  • Volume49628
  • P/E Ratio0.18
  • Dividend Yield-%
  • EBITDA889.24M
  • Revenue TTM3858.41M
  • Revenue Per Share TTM6.43
  • Gross Profit TTM 2804.07M
  • Diluted EPS TTM0.02

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 853.65M 2232.32M 969.08M 758.14M 717.36M
Minority interest 14.53M -79.89700M 156.38M 144.71M 130.59M
Net income 541.11M 1412.61M 594.01M 510.93M 502.09M
Selling general administrative 201.72M 198.88M 221.87M 189.47M 160.06M
Selling and marketing expenses 157.66M 117.91M 107.22M 115.76M 94.89M
Gross profit 1462.06M 2804.07M 1342.58M 1083.81M 948.38M
Reconciled depreciation 317.34M 238.64M 185.36M 153.48M 77.39M
Ebit 1171.45M 2262.06M 985.55M 790.84M 734.39M
Ebitda 1488.79M 2593.62M 1264.42M 981.27M 811.78M
Depreciation and amortization 317.34M 331.56M 278.88M 190.43M 77.39M
Non operating income net other - - - - -
Operating income 1171.45M 2262.06M 985.55M 790.84M 694.58M
Other operating expenses 2720.68M 2938.00M 1628.59M 1427.01M 1226.87M
Interest expense 122.68M 98.00M 67.85M 61.00M 11.86M
Tax provision 327.06M 739.82M 359.60M 253.61M 220.44M
Interest income 95.37M 113.18M 53.12M 43.58M 59.30M
Net interest income -40.21500M -4.85100M -18.40700M -21.01200M 44.00M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 327.06M 739.82M 359.60M 253.61M 220.44M
Total revenue 3605.05M 5224.71M 2656.26M 2226.49M 1921.45M
Total operating expenses 577.70M 517.35M 314.90M 284.33M 253.80M
Cost of revenue 2142.98M 2420.65M 1313.69M 1142.68M 973.07M
Total other income expense net -317.80000M -29.73900M -16.46400M -32.69600M 22.78M
Discontinued operations - - - - -
Net income from continuing ops 526.58M 1492.51M 609.48M 504.54M 496.91M
Net income applicable to common shares - 1412.61M 594.01M 510.93M 502.09M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 5296.20M 6236.09M 4177.41M 3755.44M 3433.79M
Intangible assets 418.19M 402.45M 399.80M 398.60M 403.32M
Earning assets - - - - -
Other current assets - 469.73M 383.48M 323.05M 311.96M
Total liab 2849.22M 3441.73M 1751.04M 1395.18M 1033.15M
Total stockholder equity 2154.10M 2582.85M 2269.99M 2215.55M 2270.05M
Deferred long term liab - - - - -
Other current liab 1172.57M 2015.88M 745.39M 595.89M 261.15M
Common stock 1072.50M 1072.50M 1072.50M 1072.50M 1072.50M
Capital stock 1072.50M 1072.50M 1072.50M 1072.50M 1072.50M
Retained earnings 783.08M 1550.98M 603.32M 456.66M 396.71M
Other liab - 371.27M 275.53M 209.29M 196.81M
Good will 1285.45M 1256.41M 1259.96M 1262.24M 1269.15M
Other assets - 6.76M 5.42M 4.10M -
Cash 648.51M 891.45M 600.13M 408.89M 412.61M
Cash and equivalents - - - - -
Total current liabilities 1465.03M 2348.92M 1009.36M 828.22M 669.32M
Current deferred revenue - - - - -
Net debt -532.08600M -793.38500M -48.05500M 35.90M -195.17100M
Short term debt 22.68M 21.72M 85.93M 87.13M 50.41M
Short long term debt 22.68M 21.72M 25.42M 25.42M 25.42M
Short long term debt total 116.43M 98.07M 552.08M 444.80M 217.44M
Other stockholder equity 298.51M -40.63000M 594.17M 686.38M 1068.07M
Property plant equipment - 1517.48M 1142.28M 1046.21M 705.78M
Total current assets 1625.26M 3042.51M 1360.35M 1037.90M 1055.55M
Long term investments - - - - -
Net tangible assets - 923.98M 610.24M 554.71M 597.59M
Short term investments 167.40M 1458.72M 276.62M 221.62M 239.91M
Net receivables 395.22M 371.05M 363.77M 289.49M 263.71M
Long term debt 93.75M 76.34M 67.62M 81.31M 101.44M
Inventory 265.46M 222.61M 100.11M 84.34M 91.08M
Accounts payable 269.78M 311.32M 178.04M 145.19M 157.89M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - -459.39400M -345.94100M -267.22800M
Additional paid in capital - - - - -
Common stock total equity - - 1072.50M 1072.50M 1072.50M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 18.06M 1458.72M 276.62M -0.00100M 2378.24M
Deferred long term asset charges - - - - -
Non current assets total 3670.94M 3193.58M 2817.06M 2717.54M 2378.24M
Capital lease obligations 1062.90M 760.67M 459.04M 338.07M 90.58M
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 990.11M -1327.84400M -55.00900M 18.29M -230.75600M
Change to liabilities - 351.80M 53.82M 23.70M 64.45M
Total cashflows from investing activities - -1327.84400M -124.26800M -136.35100M -465.61400M
Net borrowings - -54.57600M -56.43400M -84.58400M 46.19M
Total cash from financing activities -1617.68700M -647.14900M -563.53600M -548.73800M -358.72900M
Change to operating activities - 0.68M -1.86600M -9.31400M 0.14M
Net income 853.65M 2232.32M 969.08M 758.14M 502.09M
Change in cash -242.93900M 291.32M 191.24M -3.71500M -272.60400M
Begin period cash flow 891.45M 600.13M 408.89M 412.61M 685.21M
End period cash flow 648.51M 891.45M 600.13M 408.89M 412.61M
Total cash from operating activities 208.73M 2269.84M 882.51M 697.41M 556.31M
Issuance of capital stock - - - - -
Depreciation 317.34M 238.64M 185.36M 153.48M 77.39M
Other cashflows from investing activities - 111.37M 51.44M 59.80M 72.67M
Dividends paid 1411.75M 478.75M 450.74M 450.50M 434.95M
Change to inventory -30.15900M -127.64300M -17.12100M 4.93M -21.14400M
Change to account receivables - -106.45800M -140.56300M -78.16700M -118.04200M
Sale purchase of stock - - - - -
Other cashflows from financing activities -167.18900M -142.98500M -87.38300M -72.82000M 96.74M
Change to netincome - 500.21M 208.87M 91.64M 51.43M
Capital expenditures 308.84M 263.74M 126.01M 218.00M 331.55M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -250.30300M 118.38M -105.72900M -58.84800M -74.59700M
Stock based compensation -7.59400M -0.86600M -3.21300M -6.39100M -
Other non cash items -704.36400M 4.85M 18.41M 17.64M 51.43M
Free cash flow -100.10900M 2006.11M 756.50M 479.42M 224.76M

Peer Comparison

Sector: Healthcare Industry: Diagnostics & Research

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IDHC
Integrated Diagnostics Holdings PLC		 -0.0001 0.02% 0.59 0.18 12.89 0.0006 2.89 0.06 0.21
DXRX
Diaceutics PLC		 - -% 145.00 - 19.72 3.52 1.85 2.71 17.28
CLBX
CelLBxHealth plc		 0.10 11.11% 1.00 - - 7.00 1.67 6.81 -1.6211
ABDX
Abingdon Health Plc		 0.55 7.59% 7.80 - 67.57 2.08 3.20 1.91 -0.2499
VRCI
Verici Dx Plc		 0.007 1.22% 0.58 - - 851.60 3.00 637.86 -1.1703

Reports Covered

Stock Research & News

View All

Profile

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 2,000 diagnostic test services, including immunology, microbiology, hematology, endocrinology, clinical chemistry, molecular biology, cytogenetics, histopathology, and radiology. The company operates in Egypt, Jordan, Sudan, and Nigeria. Integrated Diagnostics Holdings plc was founded in 1979 and is headquartered in Saint Helier, Jersey.

Integrated Diagnostics Holdings PLC

12 Castle Street, Saint Helier, Jersey, JE2 3RT

Key Executives

Name Title Year Born
Dr. Hend El Sherbini Group CEO & Exec. Director 1969
Mr. Omar Bedewy Group CFO and VP of Fin. & Strategies NA
Dr. Eissa Khorshid Chief Operating Officer NA
Nancy Fahmy Investor Relations Director NA
Mr. Mohamed Kamel Saleh Gen. Counsel 1982
Dr. Seham Ibrahim Sales Director 1969
Dr. Moushira El Saifi Head of Hematology Department NA
Dr. Mohamed Akram Abdel-Rahman Nouh Head of Pathology Department and Information Technology Administrator NA
Dr. Osama S. Zaghloul Managing Director of Ultralab 1960
Dr. Amid Abdelnour Managing Director of Biolab 1959

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.